| Proliance Sports Therapy And Rehab Of Bellevue | |
|
3101 Northup Way Ste 301, Bellevue, WA 98004-1449 | |
| (425) 462-5006 | |
| (425) 462-5019 |
| Full Name | Proliance Sports Therapy And Rehab Of Bellevue |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist - Hand |
| Location | 3101 Northup Way Ste 301, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104474808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XH1200X | Occupational Therapist - Hand | (* (Not Available)) | Primary |
| 332B00000X | Durable Medical Equipment & Medical Supplies | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Proliance Sports Therapy And Rehab Of Bellevue 510 8th Ave Ne Ste 320, Issaquah, WA 98029-5436 Ph: (425) 507-0733 | Proliance Sports Therapy And Rehab Of Bellevue 3101 Northup Way Ste 301, Bellevue, WA 98004-1449 Ph: (425) 462-5006 |
News Archive
Astellas today announced that the U.S. Food and Drug Administration has approved its New Drug Application (NDA) for the use of CRESEMBA (isavuconazonium sulfate), the prodrug for isavuconazole, for patients 18 years of age and older in the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis).
The damage caused by a heart attack triggers an inflammatory reaction which degrades the affected tissue. This response is orchestrated by immune cells that reside in the nearby pericardial adipose tissue, as a study by a team of Ludwig-Maximilians-Universitaet) in Munich shows.
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
The NRG Oncology Biospecimen Bank (NRG-BB) will be awarded six more years of funding from the National Cancer Institute (NCI) to provide biospecimen banking support for the NCI National Clinical Trials Network (NCTN) group NRG Oncology.
Type 1 diabetes, formerly called insulin-dependent diabetes, juvenile diabetes or childhood-onset diabetes, affects 1 to 2 million people in the U.S. and millions more worldwide.
› Verified 9 days ago
Kimberly Lum, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16411 Ne 24th St, Bellevue, WA 98008 Phone: 425-456-5787 | |
Teresa Suhrbier, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13010 Ne 20th St Ste 300, Bellevue, WA 98005 Phone: 425-644-6328 | |
Kristin M. Henkes, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Ms. Brooke Eytchison, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2800 Northup Way # 260, Bellevue, WA 98004 Phone: 425-827-5877 | |
Jessica Seminary, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2515 140th Ave Ne Ste E110, Bellevue, WA 98005 Phone: 425-644-4100 | |
Shu-min Lin, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 919 109th Ave Ne, Bellevue, WA 98004 Phone: 425-531-7084 | |
Laura Jo Flanigan, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 844-620-1839 |